The historical rank and industry rank for Medpace Holdings's Days Sales Outstanding or its related term are showing as below:
MEDP'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.45 Med: 45.46 Max: 52.39
Current: 46.99
During the past 11 years, Medpace Holdings's highest Days Sales Outstanding was 52.39. The lowest was 36.45. And the median was 45.46.
MEDP's Days Sales Outstanding is ranked better than 79.82% of 223
companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32
vs MEDP: 46.99
Medpace Holdings's Days Sales Outstanding
increased
from Mar. 2023 (45.11) to Mar. 2024 (48.80).
Medpace Holdings Days Sales Outstanding Historical Data
The historical data trend for Medpace Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medpace Holdings's Days Sales Outstanding
For the Diagnostics & Research subindustry, Medpace Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medpace Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Medpace Holdings's Days Sales Outstanding falls into.
Medpace Holdings Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings (NAS:MEDP) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Medpace Holdings Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Medpace Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Medpace Holdings (Medpace Holdings) Business Description
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEDP has been successfully added to your 